Cancer Drug Market Booming, Projected to Reach $233 Billion by 2029 on Precision Medicine Innovation
• Global anticancer drug market estimated to reach $172.52 billion in 2023, growing at 5.25% CAGR through 2029 to $233.02 billion • Innovations in precision medicine, targeted therapies, AI streamlining drug development transforming cancer treatment • Rising costs of drug development a key challenge, impacting pricing and accessibility • Breast cancer dominance in indication segment shows impact of disease and efforts to develop better treatments • North America holds significant market share due to advanced research infrastructure and regulatory framework